Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy

Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy (2008)

Authors:
USP affiliated authors: GATTAZ, WAGNER FARID - FM ; OJOPI, ELIDA PAULA BENQUIQUE - FM
Unidade: FM
Subjects: FARMACOGÉNITICA; DEPRESSÃO (TERAPIA;GENÉTICA); ANTIDEPRESSIVOS (USO TERAPÊUTICO); RESUMOS (EVENTOS)
Language: Inglês
Imprenta:
- Publisher place: Osaka
- Date published: 2008
Source:
- Título do periódico: Resumos
- Volume/Número/Paginação/Ano: p. 13, res. LMP21, 2008
Conference titles: World Congress on Psychiatric Genetics

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT

PRADO, Carolina M. et al. Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy. 2008, Anais.. Osaka: Faculdade de Medicina, Universidade de São Paulo, 2008. p. 13. . Acesso em: 20 abr. 2024.
APA

Prado, C. M., Moreno, R. A., Gattaz, W. F., & Ojopi, E. P. B. (2008). Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy. In Resumos (p. 13). Osaka: Faculdade de Medicina, Universidade de São Paulo.
NLM

Prado CM, Moreno RA, Gattaz WF, Ojopi EPB. Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy. Resumos. 2008 ; 13.[citado 2024 abr. 20 ]
Vancouver

Prado CM, Moreno RA, Gattaz WF, Ojopi EPB. Pharmacogenetics in the study of major depression: the impact of CYP2D6 and CYP2C19 on the present antidepressant drug therapy. Resumos. 2008 ; 13.[citado 2024 abr. 20 ]